Avant Diagnostics, Inc — Form D
Avant Diagnostics, Inc of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-20. The offering totals $113K, of which $113K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-01-20
- Form: D
- Accession: 0001477932-16-008176
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $113K
- Amount sold: $113K
- Minimum investment: $113K
- Investors: 1
- Date of first sale: 2016-01-05
- Revenue range: Decline to Disclose
- SEC file number: 021-255593
Issuer
- Name: Avant Diagnostics, Inc
- CIK: 0001451929
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 1050 30TH STREET NW, SUITE 107, WASHINGTON, DC, 20007
- Phone: 708-710-9200
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Randall Letcavage | Director | TUSTIN, CA |
| Gregg Linn | Director | Scottsdale, AZ |
| Joseph Roth | Director | Scottsdale, AZ |
| Gregg Linn | Executive Officer | Scottsdale, AZ |
| Robert Trapp | Director | New York, NY |
| Scott VanderMeer | Executive Officer | Chicago, IL |
| Michael Ruxin, M.D. | Executive Officer | Washington, DC |
| Jeff Busch | Director | Washington, DC |
| John Brugmann | Director | Washington, DC |
| Jeff Stephens | Director | Washington, DC |
Other filings by this issuer (1)
More